Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Small Cell Lung Cancer (ES-SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388875
What this trial is testing

Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
China Medical University, China 30
Large-scale testing (Phase 3)UnknownNCT04254471
What this trial is testing

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Haihe Biopharma Co., Ltd. 313
Early research (Phase 1)UnknownNCT04346914
What this trial is testing

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Lee's Pharmaceutical Limited 20
Testing effectiveness (Phase 2)UnknownNCT05228496
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Lung Cancer, Small Cell
Zhejiang Cancer Hospital 21
Not applicableUnknownNCT04985851
What this trial is testing

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Shanghai Chest Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06227546
What this trial is testing

MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Georgetown University 9
Testing effectiveness (Phase 2)UnknownNCT05896059
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhejiang Cancer Hospital 21
Early research (Phase 1)Active Not RecruitingNCT05595460
What this trial is testing

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Who this might be right for
SCLC,Extensive Stage
RayzeBio, Inc. 21
Testing effectiveness (Phase 2)Looking for participantsNCT07245446
What this trial is testing

Ivonescimab in First-Line ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso 180
Testing effectiveness (Phase 2)UnknownNCT05245994
What this trial is testing

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Who this might be right for
Lung CancerSmall Cell Lung CancerDurvalumab
Li Zhang, MD 60
Large-scale testing (Phase 3)Study completedNCT04878016
What this trial is testing

Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Lee's Pharmaceutical Limited 498
Testing effectiveness (Phase 2)Ended earlyNCT04101357
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Who this might be right for
Solid TumorExtensive-stage Small Cell Lung Cancer
BioNTech SE 54
Testing effectiveness (Phase 2)Looking for participantsNCT06758700
What this trial is testing

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Thoracic NeoplasmsLung Neoplasms+1 more
Shanghai Pulmonary Hospital, Shanghai, China 15
Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06223711
What this trial is testing

Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Universität des Saarlandes 43
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938817
What this trial is testing

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

Who this might be right for
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 110
Not applicableNot Yet RecruitingNCT07400575
What this trial is testing

Anlotinib in Cross-line Treatment of NSCLC and SCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)SCLC, Extensive Stage
Henan Cancer Hospital 350
Testing effectiveness (Phase 2)UnknownNCT05731518
What this trial is testing

SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small Cell Lung Cancer
Biocity Biopharmaceutics Co., Ltd. 67
Not applicableUnknownNCT06530797
What this trial is testing

Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 2,000
Next Page